Skip to main content

Part of the book series: Updates in Surgery ((UPDATESSURG))

  • 897 Accesses

Abstract

Pretreatment and preoperative assessment of peritoneal carcinomatosis (PC) can be very challenging in the field of imaging, and a comprehensive study could require integration of multidetector computed tomography (MDCT), magnetic resonance imaging (MRI) with conventional and diffusion-weighted sequences, and positron emission tomography (PET) or PET/CT [1, 2]. These imaging tools are able to provide accurate information on morphology, size, and location of peritoneal implants, lymph node enlargement, and presence of ascites. A detailed preoperative assessment of PC is essential to provide the surgeon with a detailed preoperative map of carcinomatosis and allow evaluation of the radiological Peritoneal Cancer Index (PCI) [3, 4]. This score correlates with patient prognosis, and the ability to calculate it using CT and MR with diffusion-weighted imaging (DWI) before any treatment is begun can guide therapeutic management of the patient. It can differentiate patients who are candidates for surgical intervention with hyperthermic intraperitoneal chemotherapy (HIPEC) from those with a high radiological PCI and who are therefore candidates for systemic chemotherapy [5]. The principal diagnostic techniques for accurate evaluation of peritoneal malignancy are represented by MDCT, MRI, PET, and combined PET/MDCT or PET/MRI. The role of ultrasound (US) imaging is limited in peritoneal imaging. However, this imaging modality is often the first one used when peritoneal disease is discovered incidentally, and it remains one of the diagnostic techniques for image-guided biopsy to obtain a histological diagnosis [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Patel CM, Sahdev A, Reznek RH (2011) CT, MRI and PET imaging in peritoneal malignancy Cancer Imaging 11:123–139

    Article  PubMed Central  PubMed  Google Scholar 

  2. Iafrate F, Ciolina M, Laghi A et al (2012) Peritoneal carcinomatosis: imaging with 64-MD-CT and 3T MRI with diffusion-weighted imaging. Abdom Imaging 37:616–627

    Article  CAS  PubMed  Google Scholar 

  3. Koh JL, Yan TD, Glenn D, Morris DL (2009) Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis. Ann Surg Oncol 16:327–333

    Article  PubMed  Google Scholar 

  4. Verwaal VJ, Bruin S, Boot H et al (2008) 8-Year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol 15:2633–2635

    Article  Google Scholar 

  5. Esquivel J, Sticca R, Sugarbaker P et al (2007) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology. Ann Surg Oncol 14:128–133

    Article  CAS  PubMed  Google Scholar 

  6. Kim SJ, Kim HH, Kim YH et al (2009) Peritoneal metastasis: detection with 16- or 64-detector row CT in patients undergoing surgery for gastric cancer. Radiology 253:407–415

    Article  PubMed  Google Scholar 

  7. Marin D, Catalano C, Baski M et al (2010) 64-Section multi- detector row CT in the preoperative diagnosis of peritoneal carci- nomatosis: correlation with histopathological findings. Abdom Imaging 35:694–700

    Article  PubMed  Google Scholar 

  8. Pannu HK, Bristow r, Montz F, Fishman EK (2003) Multidetector CT of peritoneal cersinomatosis from ovarian cancer. Radiographics 23:687–701

    Article  PubMed  Google Scholar 

  9. Jacquet P, Jelinek JS, Steves MA, Sugarbaker PH (1993) Evaluation of computed tomography in patients with peritoneal carcinomatosis. Cancer 72:1631–1636

    Article  CAS  PubMed  Google Scholar 

  10. Amendola MA (1985) The role of CT in the evaluation of ovarian malignancy. CRC Crit Rev Diagn Imaging 24:329–368

    CAS  Google Scholar 

  11. Coakley FV, Hricak H (1999) Imaging of peritoneal and mesenteric disease: key concepts for the clinical radiologist. Clin Radiol 54:563–574

    Article  CAS  PubMed  Google Scholar 

  12. Bristow RE, Duska LR, Lambrou NC et al (2000) A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography. Cancer 89:1532–1540

    Article  CAS  PubMed  Google Scholar 

  13. Jang YJ, Kim JK, Park SB, Cho KS (2007) Variable CT findings of epithelial origin ovarian carcinoma according to the degree of histologic differentiation. Korean J Radiol 8:120–126

    Article  PubMed Central  PubMed  Google Scholar 

  14. Tempany CM, Zou KH, Silverman SG et al (2000) Staging of advanced ovarian cancer: comparison of imaging modalities—report from the Radiological Diagnostic Oncology Group. Radiology 215:761–767

    Article  CAS  PubMed  Google Scholar 

  15. De Bree E, Koops W, Kröger R et al (2004) Peritoneal carcinomatosis from colorectal or appendiceal origin: correlation of pre-operative CT with intraoperative findings and evaluation of interobserver agreement. J Surg Oncol 86:64–73

    Article  PubMed  Google Scholar 

  16. Coakley FV, Choi P, Poturi B et al (2002) Peritoneal metastases detection with spiral CT in patient with ovarian cancer. Radiology 223:495–499

    Article  PubMed  Google Scholar 

  17. Patel CM, Sahdev A, Reznek RH (2011) CT, MRI and PET imaging in peritoneal malignancy. Cancer Imaging 11:123–139

    Article  PubMed Central  PubMed  Google Scholar 

  18. Woodward PJ, Hosseinzadeh K, Saenger JS (2004) From the archives of the AFIP: radio- logic staging of ovarian carcinoma with pathologic correlation. RadioGraphics 24:225–246

    Article  PubMed  Google Scholar 

  19. Low RN, Barone RM, Lacey C et al (1997) Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT. Radiology 204:513–520

    Article  CAS  PubMed  Google Scholar 

  20. Fujii S, Matsusue E, Kanasaki Y et al (2008) Detection of peritoneal dissemination in gynecological malignancy: evaluation by diffusion-weighted MR imaging. Eur Radiol 18:18–23

    Article  PubMed  Google Scholar 

  21. Low RNI, Barone RM (2012) Combined diffusion-weighted and gadolinium-enhanced MRI can accurately predict the peritoneal cancer index preoperatively in patients being considered for cytoreductive surgical procedures. Ann Surg Oncol 19:1394–1401

    Article  PubMed  Google Scholar 

  22. Low RN (2007) MR imaging of the peritoneal spread of malignancy. Abdom Imaging 32:26783

    Article  Google Scholar 

  23. Kyriazi S, Collins DJ, Morgan VA et al (2010) Diffusion-weighted imaging of peritoneal disease for noninvasive staging of advanced ovarian cancer. Radiographics 30:1269–1285

    Article  PubMed  Google Scholar 

  24. Low RN (2007) MR imaging of the peritoneal spread of malignancy. Abdom Imaging 32:267–283

    Article  PubMed  Google Scholar 

  25. Low RN, Sebrechts CP, Barone RM, Muller W (2009) Diffusion-weighted MRI of peritoneal tumors: comparison with conventional MRI and surgical and histopathologic findings—a feasibility study. AJR Am J Roentgenol 193:461–470

    Article  PubMed  Google Scholar 

  26. Koh DM, Collins DJ (2007) Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 188:1622–1635

    Article  PubMed  Google Scholar 

  27. Kitajima K, Murakami K et al (2011) Present and future of FDG-PET/CT in ovarian cancer. Ann Nucl Med 25:155–164

    Article  CAS  PubMed  Google Scholar 

  28. Fanti S, Nanni C et al (2006) Supra-clavicular lymph node metastatic spread in patients with ovarian cancer disclosed a 18F-FDG-PET/CT: an unusual finding. Cancer Imaging 23:20–23

    Article  Google Scholar 

  29. Nishiyama Y, Yamamoto Y et al (2008) Monitoring the neoadjuvant therapy response in gynecological cancer patients using FDG PET. Eur J Nucl Med Mol Imaging 35:287–295

    Article  PubMed  Google Scholar 

  30. Yuan Y, Gu ZX et al (2012) Computer tomography, magnetic resonance imaging, and positron emission tomography or positron emission tomography/computer tomography for detection of metastatic lymphnodes in patients with ovarian cancer: a meta-analysis. Eur J Radiol 81:1002–1006

    Article  PubMed  Google Scholar 

  31. Esquivel J, Sticca R, Sugarbaker P, Levine E, Yan TD, Alexander R, Baratti D, Bartlett D, Barone R, Barrios P, Bieligk S, Bretcha-Boix P, Chang CK, Chu F, Chu Q, Daniel S, de Bree E, Deraco M, Dominguez-Parra L, Elias D, Flynn R, Foster J, Garofalo A, Gilly FN, Glehen O, Gomez-Portilla A, Gonzalez-Bayon L, Gonzalez-Moreno S, Goodman M, Gushchin V, Hanna N, Hartmann J, Harrison L, Hoefer R, Kane J, Kecmanovic D, Kelley S, Kuhn J, Lamont J, Lange J, Li B, Loggie B, Mahteme H, Mann G, Martin R, Misih RA, Moran B, Morris D, Onate-Ocana L, Petrelli N, Philippe G, Pingpank J, Pitroff A, Piso P, Quinones M, Riley L, Rutstein L, Saha S, Alrawi S, Sardi A, Schneebaum S, Shen P, Shibata D, Spellman J, Stojadinovic A, Stewart J, Torres-Melero J, Tuttle T, Verwaal V, Villar J, Wilkinson N, Younan R, Zeh H, Zoetmulder F, Sebbag G; Society of Surgical Oncology Annual Meeting (2007) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Ann Surg Oncol 14:128–133

    Article  CAS  PubMed  Google Scholar 

  32. Nougaret S, Addley HC, Colombo PE et al (2012) Ovarian carcinomatosis: how the radiologist can help plan the surgical approach. Radiographics 32:1775–800

    Article  PubMed  Google Scholar 

  33. Sugarbaker PH, Ronnett BM, Archer A et al (1997) Pseudomyxoma peritonei syndrome. Adv Surg 30:233–80

    Google Scholar 

  34. Sugarbaker PH (1999) Results of treatment of 385 patients with peri- toneal surface spread of appendiceal malignancy. Ann Surg Oncol 6:727–31

    Article  CAS  PubMed  Google Scholar 

  35. Vaira M, Cioppa T, D’Amico S et al (2010) Peritoneal colorectal car- cinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol 28:63–68

    Article  Google Scholar 

  36. Glehen O, Kwiatkowski F, Sugarbaker PH et al (2005) Cytoreductive surgery combined with perioperative intraperitoneal chemother- apy for the management of peritoneal carcinomatosis from colo- rectal cancer: a multi-institutional study. J Clin Oncol 22:3284–3292

    Article  Google Scholar 

  37. Klumpp BDI, Schwenzer N, Aschoff P et al (2013) Preoperative assessment of peritoneal carcinomatosis: intraindividual comparison of 18F-FDG PET/CT and MRI. Abdom Imaging 38:64–71

    Article  PubMed  Google Scholar 

  38. Chang MC, Chen JH, Liang JA et al (2013) PET or PET/CT for detection of peritoneal carcinomatosis: a meta-analysis. Clin Nucl Med 38:623–629

    Article  PubMed  Google Scholar 

  39. Glehen O, Kwiatkowski F, Sugarbaker PH et al (2004) Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol 22:3284–3292

    Article  CAS  PubMed  Google Scholar 

  40. Yan TD, Sim J, Morris DL (2007) Selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and perioperative intraperitoneal chemotherapy. Ann Surg Oncol 14:1807–1817

    Article  PubMed  Google Scholar 

  41. Bakrin N, Bereder JM, Decullier E et al (2013) Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for advanced ovarian carcinoma: a French multicentre retrospective cohort study of 566 patients. Eur J Surg Oncol 39:1435–1443

    Article  CAS  PubMed  Google Scholar 

  42. Glehen O, Gilly FN, Boutitie F et al (2010) Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients. Cancer 116:5608–5618

    Article  PubMed  Google Scholar 

  43. Yan TD, Morris DL, Shigeki K et al (2008). Preoperative investigations in the management of peritoneal surface malignancy with cytoreductive surgery and perioperative intraperitoneal chemotherapy: Expert consensus statement. J Surg Oncol 98:224–227

    Article  PubMed  Google Scholar 

  44. Rutten MJ, Leeflang MM, Kenter GG et al (2014) Laparoscopy for diagnosing resectability of disease in patients with advanced ovarian cancer. Cochrane Database Syst Rev 21;2:CD009786

    Google Scholar 

  45. Pomel C, Appleyard TL, Gouy S et al (2005). The role of laparoscopy to evaluate candidates for complete cytoreduction of peritoneal carcinomatosis and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol 31:540–543

    Article  CAS  PubMed  Google Scholar 

  46. Garofalo A, Valle M (2009) Laparoscopy in the management of peritoneal carcinomatosis. Cancer J 15:190–195

    Article  PubMed  Google Scholar 

  47. Laterza B, Kusamura S, Baratti D et al (2009) Role of explorative laparoscopy to evaluate optimal candidates for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal mesothelioma. In Vivo 23:187–190

    PubMed  Google Scholar 

  48. Fagotti A, Ferrandina G, Fanfani F et al (2006) A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study. Ann Surg Oncol 13:1156–1161

    Article  PubMed  Google Scholar 

  49. Fagotti A, Ferrandina G, Fanfani F et al (2008) Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma. Am J Obstet Gynecol 199:642.e1–6

    Google Scholar 

  50. Zivanovic O, Sonoda Y, Diaz JP et al (2008) The rate of port-site metastases after 2251 laparoscopic procedures in women with underlying malignant disease. Gynecol Oncol 111:431–437

    Article  PubMed  Google Scholar 

  51. Wang PH, Yuan CC, Lin G et al (1999) Risk factors contributing to early occurrence of port site metastases of laparoscopic surgery for malignancy. Gynecol Oncol 72:38–44

    Article  CAS  PubMed  Google Scholar 

  52. van Dam PA, DeCloedt J, Tjalma WA et al (1999) Trocar implantation metastasis after laparoscopy in patients with advanced ovarian cancer: can the risk be reduced? Am J Obstet Gynecol 181:536–541

    Article  PubMed  Google Scholar 

  53. Nagarsheth NP, Rahaman J, Cohen CJ et al (2004) The incidence of port-site metastases in gynecologic cancers. JSLS 8:133–139

    PubMed Central  PubMed  Google Scholar 

  54. Iversen LH, Rasmussen PC, Laurberg S (2013) Value of laparoscopy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis. Br J Surg 100:285–292

    Article  CAS  PubMed  Google Scholar 

  55. Sugarbaker PH (Editor), van der Speeten K, Stuart OA et al (2012) Cytoreductive Surgery & Perioperative Chemotherapy for Peritoneal Surface Malignancy. Textbook and Video Atlas. Cine-Med Publishing: Woodbury, CT, pp. 84–85

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Franco Iafrate .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Italia

About this chapter

Cite this chapter

Iafrate, F., Ciolina, M., Cavallini, C., Biacchi, D., Naticchioni, E., Laghi, A. (2015). Diagnostic Imaging and Laparoscopy. In: Di Giorgio, A., Pinto, E. (eds) Treatment of Peritoneal Surface Malignancies. Updates in Surgery. Springer, Milano. https://doi.org/10.1007/978-88-470-5711-1_6

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-5711-1_6

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-5710-4

  • Online ISBN: 978-88-470-5711-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics